Luteolin Exhibits Anxiolytic and Antidepressant Potential in Parkinson’s Disease Rat: Antioxidant and Anti-Inflammatory Effects
Rejuvenation Research · 2025
DOI: 10.1089/rej.2024.0045 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rejuvenation Research, 2025. Verfasst von Ruifang She und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, Jinan Central Hospital, Shandong University, Jinan City, People's Republic of China. Hauptthemen laut MEDLINE: Luteolin, Antioxidants, Anti-Inflammatory Agents, Antidepressive Agents. Die Arbeit wurde bisher 16-mal zitiert (Crossref) und nennt 74 Literaturangaben.
Abstract (Originalsprache)
Parkinson’s disease (PD) is accompanied by a complex array of nonmotor and motor manifestations. The exploration of anti-inflammatory and antioxidant active ingredient as potential therapeutic interventions in PD-associated mood alterations has gained significant attention. This study aimed to assess the antidepressant and anxiolytic properties of luteolin (LTN), a potent antioxidant and anti-inflammatory component, using a 6-hydroxydopamine (6-OHDA)-induced animal model of PD. Rats were administered LTN (10, 25, and 50 mg/kg, per oral) and fluoxetine (10 mg/kg/per oral) over a 28-day period. Behavioral tests were employed to estimate the depression- and anxiety-like behaviors. Rats treated with LTN exhibited significant improvement in 6-OHDA-induced mood alterations, as per behavioral tests. Additionally, LTN treatment led to increased hippocampal levels of catalase and superoxide dismutase, and a reduction in malondialdehyde. LTN downregulated the gene expression of nuclear factor kappa B (NF-κB)/nod-like receptor (NLR) pyrin domain-containing 3 (NLRP3) axis components, including NF-κB, NLRP3, ASC, and Caspase1 and reduced the protein level of pro-inflammatory cytokines, including interleukin (IL)-6, interleukin (IL)-1β, and tumor necrosis factor alpha (TNF-α), in addition to augmenting the protein levels of TNF-α, IL-1β, and IL-6. Furthermore, LTN exhibited an upregulatory effect on the anti-inflammatory cytokine IL-10 within the hippocampus of 6-OHDA-induced PD rats. Also, molecular docking showed higher affinity between LTN and NF-κB/NLRP3 axis components. These findings highlight the potential anxiolytic and antidepressant impacts of LTN through its antioxidant and anti-inflammatory mechanisms against 6-OHDA-induced alterations in a rat PD model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Neurology, Jinan Central Hospital, Shandong University, Jinan City, People's Republic of China.
- Department of Neurology, The Affiliated Taian City Central Hospital of Qingdao University, Taian City, People's Republic of China.
- Department of Neurology, The Second People's Hospital of Lianyungang City, Lianyungang City, People's Republic of China.
- Encephalopathy Department, Zibo Hospital of Integrated Traditional Chinese and Western Medicine, Zibo City, People's Republic of China.
- Department of Pulmonary and Critical Care Medicine, The Affiliated Taian City Central Hospital of Qingdao University, Taian City, People's Republic of China.
- Department of Radiology, The Affiliated Taian City Central Hospital of Qingdao University, Taian City, People's Republic of China.
Zitieren
APA
She, R., Zhang, Z., Han, M., Zhao, D., Li, X., Zhou, J., Chang, Y., Zhang, X., & Li, X. (2025). Luteolin Exhibits Anxiolytic and Antidepressant Potential in Parkinson’s Disease Rat: Antioxidant and Anti-Inflammatory Effects. Rejuvenation Research. https://doi.org/10.1089/rej.2024.0045
Vancouver
She R, Zhang Z, Han M, Zhao D, Li X, Zhou J, et al. Luteolin Exhibits Anxiolytic and Antidepressant Potential in Parkinson’s Disease Rat: Antioxidant and Anti-Inflammatory Effects. Rejuvenation Research. 2025. doi:10.1089/rej.2024.0045
BibTeX
@article{She2025,
author = {She, Ruifang and Zhang, Zhaoting and Han, Miaomiao and Zhao, Dapeng and Li, Xiangting and Zhou, Jian and Chang, Yanyan and Zhang, Xinping and Li, Xiaohong},
title = {Luteolin Exhibits Anxiolytic and Antidepressant Potential in Parkinson’s Disease Rat: Antioxidant and Anti-Inflammatory Effects},
journal = {Rejuvenation Research},
year = {2025},
doi = {10.1089/rej.2024.0045}
}
EUVIMED